VBI Vaccines Appoints Christopher McNulty as Chief Financial Officer and Head of Business Development
15 août 2018 08h00 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Aug. 15, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company, today announced the appointment of Christopher McNulty as...
Repligen Reports Second Quarter 2017 Financial Results
03 août 2017 07h30 HE
|
Repligen Corporation
Record quarterly revenue of $32.5 millionFirst half 2017 revenue growth of 16% or 18% at constant currencyEnters agreement to acquire Spectrum, Inc., which closed August 1Prices follow-on offering...
Repligen to Report First Quarter 2016 Financial Results
29 avr. 2016 11h23 HE
|
Repligen Corporation
WALTHAM, Mass., April 29, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report first quarter 2016 financial results on Thursday, May 5,...
Repligen to Report Second Quarter 2015 Financial Results
29 juil. 2015 07h30 HE
|
Repligen Corporation
WALTHAM, Mass., July 29, 2015 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that it will report second quarter 2015 financial results on Thursday, August 6, 2015. The...
Repligen to Present at Jefferies 2015 Healthcare Conference
26 mai 2015 13h00 HE
|
Repligen Corporation
WALTHAM, Mass., May 26, 2015 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq:RGEN) today announced its upcoming presentation at the Jefferies 2015 Healthcare Conference to be held June 1-4,...
Repligen Reports First Quarter 2015 Financial Results
07 mai 2015 07h30 HE
|
Repligen Corporation
- Product Sales Increase 45% to a Record $20.8 Million -- Conference Call and Webcast Today at 8:30 a.m. EDT - WALTHAM, Mass., May 7, 2015 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq:RGEN)...